Outcomes | Group | Baseline | Between groups at 6 weeks A) | Within groups (6 weeks–baseline) B) | |||
---|---|---|---|---|---|---|---|
 |  | Mean (SD) | Mean (SD) | Diff. (95% CI) | p-value | Diff (95% CI) | p-value |
TAS | INT |  | 4.63 (1.1) | 0.08 (−0.44, 0.59) | 0.760 |  |  |
CTRL | Â | 4.55 (1.1) | Â | Â | Â | Â | |
CSQ | INT |  | 24.42 (5.0) | 0.24 (−1.85, 2.32) | 0.819 |  |  |
CTRL | Â | 24.18 (4.0) | Â | Â | Â | Â | |
BASIS-32 †| INT | 1.05 (0.5) | 1.00 (0.5) | 0.02 (−0.20, 0.24) | 0.882 | −0.05 (−0.21, 0.12) | 0.551 |
CTRL | 1.23 (0.5) | 1.08 (0.6) |  |  | −0.15, (−0.33, 0.03) | 0.107 | |
PAM | INT | 35.36 (9.1) | 38.58 (7.7) | 1.58 (−2.28, 5.44) | 0.417 | 3.22 (0.70, 5.74)* | 0.014 |
CTRL | 36.09 (9.1) | 37.34 (10.8) |  |  | 1.25 (−2.43, 4.94) | 0.495 | |
MCS (SF-12) | INT | 38.19 (8.4) | 40.63 (9.2) | 0.03 (−3.5, 3.6) | 0.989 | 2.44 (−0.49, 5.38) | 0.100 |
CTRL | 38.08 (5.9) | 40.55 (7.9) |  |  | 2.47 (−0.21, 5.16) | 0.070 | |
PCS (SF-12) | INT | 48.05 (7.6) | 49.10 (8.9) | 0.92 (−2.05, 3.89) | 0.539 | 1.04 (−1.06, 3.14) | 0.321 |
CTRL | 48.29 (7.9) | 48.35 (8.7) |  |  | 0.69 (−2.22, 2.36) | 0.952 | |
ORS | INT | 18.64 (8.2) | 22.17 (9.2) | 1.73 (−1.89, 5.35) | 0.344 | 3.53 (0.99, 6.06)* | 0.008 |
CTRL | 16.83 (6.7) | 19.33 (8.8) |  |  | 2.51 (−0.41, 5.43) | 0.090 | |
SRS | INT |  | 31.88 (7.9) | 1.46 (−2.28, 5.19) | 0.440 |  |  |
CTRL | Â | 30.43 (8.3) | Â | Â | Â | Â | |
PM | INT | 5.34 (0.8) | 5.59 (0.6) | 0.29 (0.00, 0.57)* | 0.050 | 0.25 (−0.06, 0.57) | 0.113 |
CTRL | 5.31 (0.8) | 5.30 (0.8) |  |  | −0.02 (−0.23, 0.19) | 0.874 | |
PP | INT |  | 4.43 (1.0) | −0.09 (−0.52, 0.34) | 0.663 |  |  |
 | CTRL |  | 4.52 (0.9) |  |  |  |  |